Evidence map›Paper›PMID 26862303›Full record

ArticleCentral-European journal of immunology2015

Evaluation of anti-inflammatory and analgesic activities of extracts from herb of Chelidonium majus L.

Przemysław Łukasz Mikołajczak, Bogdan Kędzia, Marcin Ożarowski, Radosław Kujawski, Anna Bogacz, Joanna Bartkowiak-Wieczorek, Wojciech Białas, Agnieszka Gryszczyńska, Waldemar Buchwald, Michał Szulc and 5 more

Open access · goldAbstract read
In one paragraph

Article in Central-European journal of immunology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Plants (Basel, Switzerland) · 2025
    Review
  3. Sanguinarine-Chelerythrine fromPharmaceutics · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Journal of microbiology and biotechnology · 2022
    Article
  9. Sanguinarine-Chelerythrine Fraction ofOxidative medicine and cellular longevity · 2022
    Article
  10. Review
  11. Article
  12. Article
  13. The Anticancer Effect of Natural Plant Alkaloid Isoquinolines.International journal of molecular sciences · 2021
    Review
  14. Review
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Przemysław Łukasz MikołajczakDepartment of Pharmacology, Poznan University of Medical Sciences, Poznan, Poland; Department of Pharmacology and Phytochemistry, Institute of Natural Fibers and Medicinal Plants, Poznan, Poland.
Bogdan KędziaDepartment of Pharmacology and Phytochemistry, Institute of Natural Fibers and Medicinal Plants, Poznan, Poland.
Marcin OżarowskiDepartment of Pharmacology and Phytochemistry, Institute of Natural Fibers and Medicinal Plants, Poznan, Poland; Department of Pharmaceutical Botany and Plant Biotechnology, Poznan University of Medical Sciences, Poznan, Poland.
Radosław KujawskiDepartment of Pharmacology and Phytochemistry, Institute of Natural Fibers and Medicinal Plants, Poznan, Poland.
Anna BogaczDepartment of Stem Cells and Regenerative Medicine, Institute of Natural Fibres and Medicinal Plants, Poznan, Poland; Laboratory of Experimental Pharmacogenetics, Department of Clinical Pharmacy and Biopharmacy, Poznan University of Medical Sciences, Poznan, Poland.
Joanna Bartkowiak-WieczorekLaboratory of Experimental Pharmacogenetics, Department of Clinical Pharmacy and Biopharmacy, Poznan University of Medical Sciences, Poznan, Poland.
Wojciech BiałasDepartment of Biotechnology and Food Microbiology, Poznan University of Life Sciences, Poznan, Poland.
Agnieszka GryszczyńskaDepartment of Pharmacology and Phytochemistry, Institute of Natural Fibers and Medicinal Plants, Poznan, Poland.
Waldemar BuchwaldDepartment of Botany, Breeding and Agricultural Technology for Medicinal Plants, Institute of Natural Fibers and Medicinal Plants, Poznan, Poland.
Michał SzulcDepartment of Pharmacology, Poznan University of Medical Sciences, Poznan, Poland.
Natalia WasiakDepartment of Pharmacology, Poznan University of Medical Sciences, Poznan, Poland.
Małgorzata Górska-PauksztaLaboratory of Experimental Pharmacogenetics, Department of Clinical Pharmacy and Biopharmacy, Poznan University of Medical Sciences, Poznan, Poland.
Justyna BaraniakDepartment of Pharmacology and Phytochemistry, Institute of Natural Fibers and Medicinal Plants, Poznan, Poland.
Bogusław CzernyLaboratory of Experimental Pharmacogenetics, Department of Clinical Pharmacy and Biopharmacy, Poznan University of Medical Sciences, Poznan, Poland; Department of General Pharmacology and Pharmacoeconomics, Pomeranian Medical University, Szczecin, Poland.
Agnieszka Seremak-MrozikiewiczDepartment of Pharmacology and Phytochemistry, Institute of Natural Fibers and Medicinal Plants, Poznan, Poland; Division of Perinatology and Women's Diseases, Poznan University of Medical Sciences, Poznan, Poland; Laboratory of Molecular Biology, Poznan University of Medical Sciences, Poznan, Poland.
Institute of Natural Fibres and Medicinal Plants · PLPoznan University of Medical Sciences · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of the study was to evaluate analgesic activity ("hot plate" test), anti-inflammatory activity (carrageenan-induced paw edema) and locomotor activity in rats under the influence of three fractions of Chelidonium majus herb extract: full water extract (FWE), protein enriched fraction (PEF), and non-protein fraction (NPF). Effects of the fractions on the level of chosen cytokines and their mRNA levels were also assessed using lipopolysaccharide (LPS) administration as a proinflammatory cue. All fractions and diclofenac did not affect the locomotor activity of rats in comparison with the control group. FWE and PEF three hours after administration showed statistically significant analgesic activities comparable to morphine (p < 0.05). A slight reduction in rat paw edema was observed after three (comparable with diclofenac) and six hours in the NPF group. FWE revealed a statistically significant pro-inflammatory effect after three hours in comparison with the control group. Peripheral IL-1 and IL-4 cytokine concentrations were reduced under FWE and NPF, PEF fractions. The combination of FWE, PEF and NPF together with LPS showed only the effects of LPS. We suggest that protein enriched fraction (PEF) produced centrally mediated (morphine-like) analgesic action, whereas the anti-inflammatory potential was shown only after LPS-induced inflammation. The precise mechanisms involved in the production of anti-nociceptive and anti-inflammatory responses of studied fractions are not completely understood, but they may be caused rather by the presence of protein more than alkaloids-enriched fraction. This fraction of the extract could be used as an alternative therapy for the prevention of inflammatory-related diseases in the future, but further studies are needed.

Indexed as

analgesicanti-inflammatoryChelidonium majus aqueous extractLPS–induced ratsmRNAnon-protein fractionproinflammatory cytokinesprotein enriched fraction

Identifiers

PMID26862303
PMCPMC4737735
OpenAlexW2324447997

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.